11 results · 29ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

AART PECTORALIS IMPLANT

FDA 510(k)
FDA Class 2 ·Ear, Nose, Throat

NA

FDA UDI
STERILMED, INC.·10888551021333·BUR CARBIDE CYLINDRICAL 2 FLUTES

ULTRAPOWER

FDA UDI
Conmed Corporation·10845854000809·ULTRAPOWER BUR, ROUND/CYLINDRICAL (LIME), 3 MM

T:SLIM G5 SYSTEM

FDA Adverse Event
Malfunction ·TANDEM DIABETES CARE·Product code OYC·March 27, 2018

DANIELS SHARPSMART REUSABLE SHARPS CONTAINER

FDA 510(k)
FDA Class 2 ·General Hospital

ULTEGRA SYSTEM RAPID PLATELET FUNCTION ASSAY (RPFA)

FDA 510(k)
FDA Class 2 ·Hematology

ADVIA CENTAUR XP HBC TOTAL (HBCT) ASSAY

FDA Adverse Event
Malfunction ·SIEMENS HEALTHCARE DIAGNOSTICS, INC.·Product code LOM·March 26, 2013

CL MICRO EXT SET W/CL INJ SITE60IN 1.5M LL 0.5ML STERILE NON

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - AIBONITO·Product code FPA·March 17, 2011

NEUROTHERM DISPOSABLE RADIOFREQUENCY CANNULA

FDA Adverse Event
Malfunction ·NEUROTHERM, INC.·Product code GXI·July 8, 2014

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.

FDA Enforcement
Class II ·Terminated·Welch Allyn Protocol, Inc·January 15, 2014